50 ML rituximab 10 MG/ML Injection — RxCUI 1657867
RxNorm drug concept · Semantic clinical drug
RxCUI 1657867
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1657867
Official name50 ML rituximab 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrituximab 500 MG per 50 ML Injection; riTUXimab 500 MG in 50 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)7,969 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Rituximab Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, absolutely — and it's one of the most important parts of your treatment. Rituximab can cause serious reactions during or shortly after the infusion, and these are most likely...
- Why am I being watched so closely during my infusion — is that normal?
- It's really important that you mention this to your doctor before starting rituximab, if you haven't already. Rituximab can cause the hepatitis B virus to 'wake up' again — a proce...
- I had hepatitis B years ago — is that a problem?
🕸️ Concept Web — How 50 ML rituximab 10 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
50 ML rituximab 10 MG/ML Injection
RxCUI 1657867 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Rituximab
121191IN
-
Rituximab
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Rituxan
226754BN
-
Rituxan
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Rituximab Injection
1657861SCDF -
Rituximab Injectable Product
1157967SCDG -
Rituximab Injection [Rituxan]
1657863SBDF -
Rituxan Injectable Product
1185345SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Rituximab Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Rituximab 10 MG/ML
316648SCDC -
50 ML rituximab 10 MG/ML Injection [Rituxan]
1657868SBD -
Rituximab 10 MG/ML [Rituxan]
573051SBDC
-
Rituximab 10 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Rituximab 10 MG/ML
SCDC · 316648 -
Rituximab Injection
SCDF · 1657861 -
Rituximab Injectable Product
SCDG · 1157967
Brand-Name Concepts
-
50 ML rituximab 10 MG/ML Injection [Rituxan]
SBD · 1657868 -
Rituximab 10 MG/ML [Rituxan]
SBDC · 573051 -
Rituximab Injection [Rituxan]
SBDF · 1657863 -
Rituxan Injectable Product
SBDG · 1185345 -
Rituxan
BN · 226754
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 1657867 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50242-0051-21 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21) / 10 mL in 1... | Rituxan | Genentech, Inc. | 1997-11-26 |
| 50242-0053-06 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-053-06) / 50 mL in 1... | Rituxan | Genentech, Inc. | 1997-11-26 |
Observed labelers:
Genentech, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9312 | Inj., rituximab, 10 mg | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.